Genetic Technologies (STU:DU8) Operating Cash Flow per Share : €-0.05 (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Genetic Technologies Operating Cash Flow per Share?

Genetic Technologies's operating cash flow per share for the three months ended in Dec. 2023 was €-0.01. Genetic Technologies's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 11.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 22.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 28.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Genetic Technologies's Operating Cash Flow per Share or its related term are showing as below:

STU:DU8' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -120.4 Med: 18.35 Max: 67.8
Current: 11.2

During the past 13 years, Genetic Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.80% per year. The lowest was -120.40% per year. And the median was 18.35% per year.

STU:DU8's 3-Year OCF Growth Rate is ranked better than
66.67% of 177 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.8 vs STU:DU8: 11.20

Genetic Technologies Operating Cash Flow per Share Historical Data

The historical data trend for Genetic Technologies's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Operating Cash Flow per Share Chart

Genetic Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.14

-0.08

-0.05

-0.04

-0.06

Genetic Technologies Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.01	-0.02	-0.02	-0.01	-0.01

Competitive Comparison of Genetic Technologies's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Genetic Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Technologies's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genetic Technologies's Price-to-Operating-Cash-Flow falls into.

Genetic Technologies Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Genetic Technologies's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	-6.023	/	101.381
	=	-0.06

Genetic Technologies's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-0.659	/	115.417
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.05

Genetic Technologies Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies (STU:DU8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (STU:DU8) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

GENE:USA GTG:Australia

Address

60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065

Website

https://www.gtglabs.com

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Genetic Technologies (STU:DU8) Headlines

No Headlines